Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil. 1981

M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler

Following i.v. administration, the plasma concentration-time curve of verapamil could best be described by either a mono- or biexponential equation. Total plasma clearance (1.26 1/min) approached liver blood flow (1.51/min), so it can be concluded that its clearance is liver blood flow-dependent. Although absorption was almost complete after oral administration, absolute bioavailability (20%) was low, due to extensive hepatic first-pass metabolism. The approach using stable isotope-labelled and unlabelled drug permits simultaneous administration by the intravascular and extravascular routes, thus allowing determination of absolute bioavailability in a single experiment.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D003903 Deuterium The stable isotope of hydrogen. It has one neutron and one proton in the nucleus. Deuterons,Hydrogen-2,Hydrogen 2
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
January 1977, Arzneimittel-Forschung,
M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
January 1989, European journal of clinical pharmacology,
M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
September 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
February 1986, Diabetologia,
M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
May 2022, Sensors (Basel, Switzerland),
M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
August 1976, Research communications in chemical pathology and pharmacology,
M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
August 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
October 1976, Chemical & pharmaceutical bulletin,
M Eichelbaum, and A Somogyi, and G E von Unruh, and H J Dengler
January 2000, Journal of chromatography. B, Biomedical sciences and applications,
Copied contents to your clipboard!